News

RSS

CCNY STEM Majors Scoop Up Record Five Wins at National Conference

City College of New York science students brought home a record five wins for research poster presentations at the Annual Biomedical Research Conference for Minority Students (ABRCMS) last semester in San Jose, California.
Read More »
Molecular Biologist Susan Gottesman to Present Cosloy-Blank Lecture

Molecular biologist Dr. Susan Gottesman will deliver the 7th Annual Sharon Cosloy-Edward Blank Lecture at The City College of New York 4 p.m. Thursday, October 18. The topic of her talk will be “Bacterial Circuits with Small RNA Regulators.” The lecture, which is free and open to the public, will take place in Room 95, Shepard Hall, and will be followed by a reception in Room 150.
Read More »
New obesity measure predicts early death better than BMI

A new measure of obesity developed by a City College of New York researcher and a physician predicts early death better than BMI, the Body Mass Index.
Read More »
Gene May Link Diabetes and Alzheimer’s, CCNY Researchers Find

In recent years it became clear that people with diabetes face an ominous prospect – a far greater risk of developing Alzheimer’s disease. Now researchers at The City College of New York (CCNY) have shed light on one reason why. Biology Professor Chris Li and her colleagues have discovered that a single gene forms a common link between the two diseases.
Read More »
CCNY Announces Winner of $50,000 Kaylie Prize for Entrepreneurship

A hands-free system to help visually impaired people sense their surroundings won $50,000 for a team of five City College of New York students in the Second Annual Kaylie Prize for Entrepreneurship competition.
Read More »
Technology Eases Migraine Pain in the Deep Brain

A team of researchers that includes Dr. Marom Bikson, associate professor of biomedical engineering in CCNY’s Grove School of Engineering, has shown that a brain stimulation technology can prevent migraine attacks from occurring.
Read More »
CCNY Professor to Test Monoclonal Antibodies as Ovarian Cancer Diagnostic Reagent

MabCure Inc., (OTCBB:MBCI) a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents. The work will be performed in the laboratory of Professor Paul Gottlieb of The City College of New York’s Sophie Davis School of Biomedical Education.
Read More »
The Y Chromosome: Junk or Jewel?

Dr. David C. Page, Bryson Professor of Biology at the Massachusetts Institute of Technology, will deliver the 2012 Louis Levine – Gabriella de Beer Lecture in Genetics at The City College of New York 5 p.m. Wednesday, March 28, 2012. He will speak in The Great Hall of Shepard Hall, 160 Convent Avenue, New York. The lecture, titled “Rethinking the Rotting Y Chromosome,” is free and open to the public. A reception will follow.
Read More »
Could a NOSH-Aspirin-a-Day Keep Cancer Away?

The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be not only an extremely potent cancer-fighter, but even safer than the classic medicine cabinet staple.
Read More »
2nd Annual National Urban Health Conference Focuses on Urban Ecology Feb 23 – 26

The Greater Harlem Chamber of Commerce, along with the New York Academy of Medicine, Harlem Hospital, Emblem Health, Touro College and The City College of New York, is sponsoring the second annual National Urban Health Conference. The four-day event will take place from February 23rd to February 26th and will center on the theme of Urban Ecology.
Read More »